232 related articles for article (PubMed ID: 9311358)
1. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
Kaniecki RG
Arch Neurol; 1997 Sep; 54(9):1141-5. PubMed ID: 9311358
[TBL] [Abstract][Full Text] [Related]
2. Migraine prophylaxis with divalproex.
Mathew NT; Saper JR; Silberstein SD; Rankin L; Markley HG; Solomon S; Rapoport AM; Silber CJ; Deaton RL
Arch Neurol; 1995 Mar; 52(3):281-6. PubMed ID: 7872882
[TBL] [Abstract][Full Text] [Related]
3. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group.
Silberstein SD; Collins SD
Headache; 1999 Oct; 39(9):633-43. PubMed ID: 11284461
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
Caruso JM; Brown WD; Exil G; Gascon GG
Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
Jensen R; Brinck T; Olesen J
Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
[TBL] [Abstract][Full Text] [Related]
7. [Sodium valproate versus propranolol in the prophylactic treatment of migraine].
Kozubski W; Prusiński A
Neurol Neurochir Pol; 1995; 29(6):937-47. PubMed ID: 8714731
[TBL] [Abstract][Full Text] [Related]
8. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Klapper J
Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
He A; Song D; Zhang L; Li C
J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
[TBL] [Abstract][Full Text] [Related]
10. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
[TBL] [Abstract][Full Text] [Related]
11. Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
Ashrafi MR; Shabanian R; Zamani GR; Mahfelati F
Eur J Paediatr Neurol; 2005; 9(5):333-8. PubMed ID: 16120482
[TBL] [Abstract][Full Text] [Related]
12. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
Blumenfeld AM; Schim JD; Chippendale TJ
Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
[TBL] [Abstract][Full Text] [Related]
14. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.
Green MW; Giordano S; Jiang P; Jafari M; Smith TB
Headache; 2005 Sep; 45(8):1031-7. PubMed ID: 16109117
[TBL] [Abstract][Full Text] [Related]
15. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
16. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
